Latest Articlesddd
The Week in Review #44 Quarterly Financial Results What Was Seen and What Was Ignored History …
Spring Bank Pharmaceuticals, Gilead Sciences and HBV If Spring Bank Pharmaceuticals’ (SBPH) product inarigivir in combination …
The Week in Review #43 This Past Week After hearing hints about the trade war between …
Seattle Genetics Announced Positive Results for HER2CLIMB Trial Seattle Genetics (SGEN) announced positive topline results from …
Bayer Decision to Advance IONIS-FXI-LRx for Clotting Disorders On October 9, 2019 Ionis Pharmaceuticals (IONS) announced …
Hepion Pharmaceuticals CRV431 Decreased Liver Fibrosis and Tumor Burden in Experimental Models EDISON, NJ / ACCESSWIRE …
Reata Pharmaceuticals Omaveloxolone for Friedreich’s Ataxia On October 14, 2019 Reata Pharmaceuticals (RETA) announced the Part 2 …
RegenxBio Rebounding RegenxBio (RGNX) has the viral vectors which could safely deliver genes into the cells. …
RegenxBio Interim Data from Phase I/IIa Trial of RGX-314 for Wet AMD RegenxBio (RGNX) announced interim …
Stock Market Volatility Stocks can move up and down for various reasons but not all of …
Nektar Therapeutics Announces Two Studies of NKTR-358 Nektar Therapeutics (NKTR) announced the initiation of two Phase 1b …
The Week in Review #42 During the Departed Week The week started with the market losing …
Prohost Letter #436 What Are We Experiencing Now? The bizarre market underperformance progressing rather than regressing …
Seattle Genetics Stock Rally Seattle Genetics (SGEN) stock has rallied today. It gained around $10; trading …
Enanta Positive Results of EPD-305 for NASH Enanta (ENTA) has positive results from the ARGON-1 Phase …
The Medicines Company ORION-10 Study for ASCVD The Medicines Company (MDCO) announced positive topline results from …
Vitiligo Vitiligo is a chronic autoimmune disease. The immune system attacks the pigment-producing melanocyte cells causing …
News from Nektar Nektar Therapeutics (NKTR) announced that new data from patients with metastatic triple-negative breast cancer, …
Prohost Letter #435 The Value of the Biotech Companies A Continuation of Prohost Letter #434 A …
bluebird bio Has Promising Results from Its Lenti-D Gene Therapy for CALD Good results have come …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
